NAD+ in Cellular Research: Mitochondrial Function and Aging Studies

Published August 2, 2026 · ROVIQ Research

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme central to cellular energy metabolism, and over the past decade it has become one of the most actively studied molecules in cell biology and aging research. This overview summarizes what current published research — primarily cell-culture and animal-model studies — actually shows across three areas: mitochondrial energy metabolism, DNA damage repair, and sirtuin-linked cellular aging.

Mitochondrial Energy Metabolism

NAD+ (and its reduced form, NADH) functions as an electron carrier in the mitochondrial reactions that generate cellular energy — the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. A 2018 study published in eLife used isotopic labeling to directly demonstrate that intact NAD+ is transported across the mitochondrial membrane in isolated mitochondria, cultured cell lines, and murine tissue, helping resolve a long-standing question about how mitochondria maintain their internal NAD+ pool (Davila et al., 2018). A related methods review outlines how NAD+ concentration is measured within mitochondria and its role in these energy-producing reactions (Li & Sauve, 2015).

DNA Damage Repair (PARP1 Pathway)

NAD+ is also the required substrate for PARP1, an enzyme that responds rapidly to DNA damage. In a 2019 cell-culture study using HeLa cells, fibroblasts, retinal pigment epithelial cells, and breast cancer cell lines, researchers used live-cell fluorescence imaging to show that PARP1 activation following DNA damage triggers a measurable, NAD+-dependent shift in cellular metabolism toward oxidative phosphorylation — directly linking NAD+ availability to how a damaged cell manages its energy metabolism during repair (Murata et al., 2019).

Sirtuins and Cellular Aging

NAD+ is a required cofactor for the sirtuin family of enzymes (SIRT1–7), which are studied for their role in cellular stress response and aging-related pathways. In a 2022 in vitro study, supplementing mesenchymal stem cells with nicotinamide mononucleotide (an NAD+ precursor) increased intracellular NAD+ and Sirt3 activity, and was associated with improved mitochondrial function and reduced markers of cellular senescence in those cultured cells (Wang et al., 2022).

The clearest in vivo (animal model) evidence in this space comes from a 2013 study in Cell Metabolism, where researchers genetically engineered mice to overexpress Sirt1 specifically in the brain. These transgenic mice showed a measurable extension in median lifespan and delayed aging-associated phenotypes, an effect the researchers traced to increased neural activity in specific hypothalamic regions (Satoh et al., 2013). This remains an animal-model finding — it does not establish the same effect in humans.